Investigating the effect of increased dopamine signaling on cerebral blood flow in Major Depressive Disorder: a double-blind randomized placebo-controlled study.
Overview
- MSB Medical School Berlin,Berlin, Germany
- Department of Education and Psychology, Freie Universität Berlin,Berlin, Germany
- Charité Research Organisation GmbH,Berlin, Germany
- SBGneuro Ltd, Littlemore,Oxford, UK
- Donders Institute, Centre for Medical Neuroscience, Radboud University Medical Centre,Nijmegen, Netherlands
- Centre for Functional MRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, University of Oxford,Oxford, UK
- Clinical Development and Operations, Boehringer Ingelheim Pharma GmbH & Co. KG,Biberach an der Riss, Germany
- Medicine Therapeutic Area CNS-Retinopathies-Emerging Areas, Boehringer Ingelheim International GmbH,Biberach an der Riss, Germany
- Private Consultant, Lübeck, Germany
Abstract
Anhedonia, a core symptom of major depressive disorder (MDD), is linked to dysfunction in reward-related brain regions and impaired dopamine (DA) signaling. This study used arterial spin labeling (ASL) to investigate the effects of a single low dose of amisulpride, a selective DA antagonist, on cerebral blood flow (CBF) in MDD patients and healthy volunteers (HVs). In a double-blind, placebo-controlled, randomized, parallel-group design, participants received either 100 mg amisulpride or placebo. N = 111 participants (MDD: n = 57; HV: n = 54) were included in the final analysis and group differences were assessed in core regions of the reward network, particularly the ventral striatum. Individual CBF values were analyzed in relation to self-reported anhedonia and depression severity. Amisulpride was associated with higher perfusion in the ventral striatum compared to placebo in both HVs and MDD patients, consistent with enhanced dopaminergic activity in this region. No significant CBF changes were observed in other areas of the reward network. Ventral striatal perfusion was significantly associated with self-reported anhedonia. Exploratory whole-brain analyses revealed higher CBF in the right frontal operculum in MDD patients compared to HVs under placebo, but not under amisulpride. In the placebo group, both anhedonia and depression severity were associated with CBF in the right frontal operculum; these associations were absent following amisulpride administration. In conclusion, we provide initial evidence of region-specific effects of amisulpride administration on CBF that are consistent with modulation of dopaminergic signaling. Increased perfusion in the ventral striatum suggests a potential dopaminergic mechanism relevant to anhedonia. These findings underscore the ventral striatum’s role in reward processing and support its involvement in the pathophysiology of anhedonia across clinical and non-clinical populations.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Data availability
The individual de-identified participant data and the statistical code can be accessed upon reasonable request from the corresponding author.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 14 authors, 2 keywords, 17 MeSH terms, 1 funder, 80 references.
Cite
This paper
Gärtner, M., Meiering, M. S., Weigner, D., Hempel, M., Gruzman, R., Carstens, L., Keicher, C., Mennes, M., Beckmann, C. F., Luippold, G., Süssmuth, S. D., Popp, M., Wunder, A., & Grimm, S. (2026). Investigating the effect of increased dopamine signaling on cerebral blood flow in Major Depressive Disorder: a double-blind randomized placebo-controlled study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
BibTeX
@article{gartner2026inve
author = {Gärtner, Matti and Meiering, Marvin S. and Weigner, David and Hempel, Moritz and Gruzman, Rebecca and Carstens, Luisa and Keicher, Christian and Mennes, Maarten and Beckmann, Christian F. and Luippold, Gerd and Süssmuth, Sigurd D. and Popp, Margot and Wunder, Andreas and Grimm, Simone},
title = {{Investigating the effect of increased dopamine signaling on cerebral blood flow in Major Depressive Disorder: a double-blind randomized placebo-controlled study}},
journal = {Neuropsychopharmacology
year = {2026},
month = jun,
volume = {51},
number = {10},
pages = {1808--1815},
publisher = {Nature Publishing Group},
issn = {0893-133X},
doi = {10.1038/
url = {https://
pmid = {42350630},
pmcid = {PMC13486671}
}
RIS
TY - JOUR
AU - Gärtner, Matti
AU - Meiering, Marvin S.
AU - Weigner, David
AU - Hempel, Moritz
AU - Gruzman, Rebecca
AU - Carstens, Luisa
AU - Keicher, Christian
AU - Mennes, Maarten
AU - Beckmann, Christian F.
AU - Luippold, Gerd
AU - Süssmuth, Sigurd D.
AU - Popp, Margot
AU - Wunder, Andreas
AU - Grimm, Simone
TI - Investigating the effect of increased dopamine signaling on cerebral blood flow in Major Depressive Disorder: a double-blind randomized placebo-controlled study
T2 - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
J2 - Neuropsychopharmacology
PY - 2026
DA - 2026/
VL - 51
IS - 10
SP - 1808
EP - 1815
SN - 0893-133X
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Investigating the effect of increased dopamine signaling on cerebral blood flow in Major Depressive Disorder: a double-blind randomized placebo-controlled study",
"container-title": "Neuropsychopharmacology
"author": [
{
"family": "Gärtner",
"given": "Matti"
},
{
"family": "Meiering",
"given": "Marvin S."
},
{
"family": "Weigner",
"given": "David"
},
{
"family": "Hempel",
"given": "Moritz"
},
{
"family": "Gruzman",
"given": "Rebecca"
},
{
"family": "Carstens",
"given": "Luisa"
},
{
"family": "Keicher",
"given": "Christian"
},
{
"family": "Mennes",
"given": "Maarten"
},
{
"family": "Beckmann",
"given": "Christian F."
},
{
"family": "Luippold",
"given": "Gerd"
},
{
"family": "Süssmuth",
"given": "Sigurd D."
},
{
"family": "Popp",
"given": "Margot"
},
{
"family": "Wunder",
"given": "Andreas"
},
{
"family": "Grimm",
"given": "Simone"
}
],
"container-title-short":
"volume": "51",
"issue": "10",
"page": "1808-1815",
"DOI": "10.1038/
"PMID": "42350630",
"PMCID": "PMC13486671",
"ISSN": "0893-133X",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
26
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1002/brb3.71581 [code]
- Blunted Reward Responsiveness During Social Feedback: Associations with Peer Victimization and Anhedonia in Socially Anxious Adolescents.Journal: Brain and behaviorIn common: structural MRI / diffusion, 5 references
- [2] doi:10.1038/s41467-026-76812-w [code]
- Assessing molecular, cellular and transcriptomic bases of laminar perfusion and cytoarchitecture coupling in the human cortex.Journal: Nature communicationsIn common: stroke, structural MRI / diffusion, 2 references
- [3] doi:10.1038/s41380-026-03560-0
- Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial.Journal: Molecular psychiatryIn common: depression, clinical / translational, 2 references
- [4] doi:10.1162/imag.a.1174 [code]
- Retinal nerve fibre layer thickness reflects characteristics of brain grey and white matter.Journal: Imaging neuroscience (Cambridge, Mass.)In common: structural MRI / diffusion, clinical / translational, 2 references
- [5] doi:10.1162/imag.a.1268 [code]
- Real-time fMRI-triggered experience sampling: A proof-of-concept study.Journal: Imaging neuroscience (Cambridge, Mass.)In common: 3 references
- [6] doi:10.1016/j.ajcnut.2026.101401
- Brain and physiological responses to flavored waters with different sweeteners: a randomized crossover study in healthy young adults.Journal: The American journal of clinical nutritionIn common: stroke, structural MRI / diffusion, clinical / translational, 1 reference
- [7] doi:10.1038/s41597-026-07746-7
- A longitudinal resource for mapping interindividual variation in the aging connectome.Journal: Scientific dataIn common: structural MRI / diffusion, 2 references
- [8] doi:10.1111/pcn.70075
- Network-level disconnectivity tracks poststroke depressive symptom improvement.Journal: Psychiatry and clinical neurosciencesIn common: depression, stroke, structural MRI / diffusion, 1 reference
- [9] doi:10.1093/braincomms/fcag290 [code]
- Functional connectivity predictors and mechanisms of symptom change in functional neurological disorder.Journal: Brain communicationsIn common: clinical / translational, 2 references
- [10] doi:10.1002/hbm.70533 [code]
- Trait-Relevant Tasks Improve Personality Prediction From Structural-Functional Brain Network Coupling.Journal: Human brain mappingIn common: structural MRI / diffusion, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
